Ironwood Pharmaceuticals, Inc. (IRWD)

IRWD presents a mixed picture with momentum and MACD slightly negative and a deeply negative CCI pointing to recent weakness, while the stochastic reading signals a possible short-term oversold condition. The 10–50 day moving averages sit above the current price, yet the 100–200 day averages remain below, producing a neutral medium/longer-term backdrop. ADX indicates a lack of strong trend and ATR shows moderate volatility, while OBV is soft. The classic pivot is just under the price, adding minor support. Technical takeaway: Neutral.